CN103068398A - 丹参组合物在制备用于冠心病二级预防的药物中的用途 - Google Patents

丹参组合物在制备用于冠心病二级预防的药物中的用途 Download PDF

Info

Publication number
CN103068398A
CN103068398A CN201180036131XA CN201180036131A CN103068398A CN 103068398 A CN103068398 A CN 103068398A CN 201180036131X A CN201180036131X A CN 201180036131XA CN 201180036131 A CN201180036131 A CN 201180036131A CN 103068398 A CN103068398 A CN 103068398A
Authority
CN
China
Prior art keywords
heart disease
coronary heart
purposes according
chinese medicine
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201180036131XA
Other languages
English (en)
Other versions
CN103068398B (zh
Inventor
闫希军
吴迺峰
闫凯
孙鹤
郭治昕
祝国光
刘巍巍
赵利斌
罗瑞芝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tasly Pharmaceutical Group Co Ltd
Original Assignee
Tasly Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tasly Pharmaceutical Group Co Ltd filed Critical Tasly Pharmaceutical Group Co Ltd
Priority to CN201180036131.XA priority Critical patent/CN103068398B/zh
Publication of CN103068398A publication Critical patent/CN103068398A/zh
Application granted granted Critical
Publication of CN103068398B publication Critical patent/CN103068398B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

本发明提供了丹参组合物在制备冠心病二级预防的药物中的应用，特别是提供了丹参组合物在制备稳定型心绞痛型冠心病二级预防和减少严重血管事件的药物中的应用。

Description

PCT国内申请，说明书已公开。

Claims (1)

  1. PCT国内申请，权利要求书已公开。
CN201180036131.XA 2010-08-06 2011-08-08 丹参组合物在制备用于冠心病二级预防的药物中的用途 Active CN103068398B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201180036131.XA CN103068398B (zh) 2010-08-06 2011-08-08 丹参组合物在制备用于冠心病二级预防的药物中的用途

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201010253344.5 2010-08-06
CN2010102533445 2010-08-06
CN201010253344 2010-08-06
CN201180036131.XA CN103068398B (zh) 2010-08-06 2011-08-08 丹参组合物在制备用于冠心病二级预防的药物中的用途
PCT/CN2011/078128 WO2012016549A1 (zh) 2010-08-06 2011-08-08 丹参组合物在制备用于冠心病二级预防的药物中的用途

Publications (2)

Publication Number Publication Date
CN103068398A true CN103068398A (zh) 2013-04-24
CN103068398B CN103068398B (zh) 2015-08-19

Family

ID=45558949

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180036131.XA Active CN103068398B (zh) 2010-08-06 2011-08-08 丹参组合物在制备用于冠心病二级预防的药物中的用途

Country Status (17)

Country Link
US (1) US9072745B2 (zh)
EP (1) EP2601958B1 (zh)
JP (2) JP6030556B2 (zh)
KR (2) KR20130073938A (zh)
CN (1) CN103068398B (zh)
AU (1) AU2011288044B8 (zh)
BR (1) BR112013002814B1 (zh)
CA (1) CA2807283C (zh)
DK (1) DK2601958T3 (zh)
EA (1) EA025307B1 (zh)
ES (1) ES2624285T3 (zh)
HK (1) HK1175994A1 (zh)
MX (1) MX353834B (zh)
MY (1) MY160768A (zh)
NZ (1) NZ606595A (zh)
SG (1) SG187715A1 (zh)
WO (1) WO2012016549A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107714857A (zh) * 2017-12-01 2018-02-23 王章琳 一种治疗心脑血管病的中药组合物及其制备方法

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110025830A1 (en) 2009-07-31 2011-02-03 3Dmedia Corporation Methods, systems, and computer-readable storage media for generating stereoscopic content via depth map creation
WO2011014419A1 (en) 2009-07-31 2011-02-03 3Dmedia Corporation Methods, systems, and computer-readable storage media for creating three-dimensional (3d) images of a scene
ES2624285T3 (es) * 2010-08-06 2017-07-13 Tasly Pharmaceutical Group Co., Ltd. Uso de una composición de Salvia miltiorrhiza en la preparación de fármacos para la prevención secundaria de una enfermedad cardíaca coronaria
US8274552B2 (en) 2010-12-27 2012-09-25 3Dmedia Corporation Primary and auxiliary image capture devices for image processing and related methods
TWI621443B (zh) 2013-07-11 2018-04-21 Tasly Pharmaceutical Group Co Ltd 中藥組合物及其用途、包含該中藥組合物之藥物製劑及複方丹參微滴丸劑、及該微滴丸劑的製備方法
CA2916963C (en) * 2013-07-11 2022-11-08 Tasly Pharmaceutical Group Co., Ltd. Traditional chinese medicine composition, and preparation and application thereof
HUE054609T2 (hu) 2013-07-11 2021-09-28 Tasly Pharmaceutical Group Co Elkészítési eljárás hagyományos kínai gyógyszer mikrocsepp pilulához, és a hagyományos kínai gyógyszer mikrocsepp pilula, amely ennek az eljárásnak az alkalmazásával van elkészítve
CN104418744B (zh) 2013-08-29 2017-03-01 天士力制药集团股份有限公司 一种新的丹酚酸化合物t、其制备方法和用途
CN104435525A (zh) * 2014-09-01 2015-03-25 周风华 防治细菌性心内膜炎的中药组合物及其制备方法
CN104800520A (zh) * 2015-04-16 2015-07-29 刘瑜 治疗心、小肠病症的红色中药包
CN104840900A (zh) * 2015-06-08 2015-08-19 刘云平 一种治疗心悸的中药
JP6520510B2 (ja) * 2015-07-15 2019-05-29 富士ゼロックス株式会社 情報処理装置及び情報処理プログラム
CN104998216A (zh) * 2015-08-19 2015-10-28 鄢明亮 一种用于预防治疗心悸的中药袋泡茶及制备方法
CN107137665B (zh) * 2017-06-02 2020-11-24 烟台大学 一种防治心肌纤维化的中药组合物及其应用
KR102127726B1 (ko) * 2018-08-29 2020-06-29 윤화순 복합 한방 생약 추출물을 포함하는 혈행 개선용 제제
KR102127706B1 (ko) * 2018-08-29 2020-06-29 윤화순 복합 한방 생약 추출물을 포함하는 혈행 개선용 제제
CN111297942A (zh) * 2019-12-23 2020-06-19 卓和药业集团有限公司 一种治疗心肌缺血的复方制剂及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1348815A (zh) * 2001-11-09 2002-05-15 天津天士力制药股份有限公司 一种预防和治疗冠心病心绞痛的药物及其制备方法和其它用途
CN1714819A (zh) * 2004-06-30 2006-01-04 天津天士力制药股份有限公司 一种治疗冠心病的药物组合物
CN1919248A (zh) * 2005-08-24 2007-02-28 天津天士力现代中药研究开发有限公司 一种治疗心脑血管病的中药制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1456323A (en) * 1974-06-06 1976-11-24 Labaz Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
KR100374416B1 (ko) * 2000-11-14 2003-03-04 노용일 고지혈증 및 협심증 예방 및 치료용 생약조성물
BRPI0116589B1 (pt) * 2000-12-22 2018-07-03 Tasly Pharmaceutical Group Co., Ltd. Composição herbal para angina pectoris, método para prepará-la e uso desta
US8486464B2 (en) * 2000-12-22 2013-07-16 Tasly Pharmaceutical Group Co. Ltd. Herbal composition for angina pectoris, method to prepare same and uses thereof
CN1202103C (zh) * 2002-05-23 2005-05-18 天津天士力制药股份有限公司 丹参总酚酸的制备方法
CN100339085C (zh) 2003-09-23 2007-09-26 天津天士力制药股份有限公司 治疗心脑血管疾病的中药组合物
CN100450501C (zh) * 2004-03-17 2009-01-14 天津天士力制药股份有限公司 一种治疗心脑血管疾病的中药制剂及其制备方法
CN1785249B (zh) 2004-12-06 2011-03-23 天津天士力制药股份有限公司 一种含有丹参的药物组合物的新用途
ES2624285T3 (es) * 2010-08-06 2017-07-13 Tasly Pharmaceutical Group Co., Ltd. Uso de una composición de Salvia miltiorrhiza en la preparación de fármacos para la prevención secundaria de una enfermedad cardíaca coronaria

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1348815A (zh) * 2001-11-09 2002-05-15 天津天士力制药股份有限公司 一种预防和治疗冠心病心绞痛的药物及其制备方法和其它用途
CN1714819A (zh) * 2004-06-30 2006-01-04 天津天士力制药股份有限公司 一种治疗冠心病的药物组合物
CN1919248A (zh) * 2005-08-24 2007-02-28 天津天士力现代中药研究开发有限公司 一种治疗心脑血管病的中药制剂

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
代林彦等: "复方丹参滴丸与片剂治疗冠心病疗效对比观察", 《华北煤炭医学院学报》 *
常以芳等: "复方丹参滴丸对冠脉造影正常AMI患者血管内皮功能的影响", 《山东医药》 *
扶桂升: "复方丹参滴丸预防冠心病患者支架术后再狭窄的临床观察", 《中国医药导报》 *
曹华等: "复方丹参滴丸在社区医疗中的应用", 《中国社区医师(医学专业半月刊)》 *
李国辉等: "复方丹参滴丸预防冠心病患者支架术后再狭窄的临床观察", 《现代中西医结合杂志》 *
沈惠球等: "复方丹参滴丸与片剂治疗冠心病心绞痛疗效比较", 《实用中西医结合临床》 *
黎君等: "复方丹参滴丸在社区冠心病防治中的优势", 《当代医学》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107714857A (zh) * 2017-12-01 2018-02-23 王章琳 一种治疗心脑血管病的中药组合物及其制备方法

Also Published As

Publication number Publication date
BR112013002814A2 (pt) 2018-02-06
EP2601958A4 (en) 2013-12-18
CA2807283C (en) 2019-05-14
ES2624285T3 (es) 2017-07-13
MY160768A (en) 2017-03-15
EP2601958A1 (en) 2013-06-12
EA201300159A8 (ru) 2014-11-28
MX353834B (es) 2018-01-31
AU2011288044B8 (en) 2014-08-07
AU2011288044B2 (en) 2014-07-17
WO2012016549A1 (zh) 2012-02-09
BR112013002814B1 (pt) 2020-10-27
JP6030556B2 (ja) 2016-11-24
EP2601958B1 (en) 2017-03-29
DK2601958T3 (en) 2017-07-17
AU2011288044A1 (en) 2013-02-21
SG187715A1 (en) 2013-03-28
US20130196005A1 (en) 2013-08-01
US9072745B2 (en) 2015-07-07
KR20150107902A (ko) 2015-09-23
HK1175994A1 (zh) 2013-07-19
CA2807283A1 (en) 2012-02-09
JP2016183201A (ja) 2016-10-20
NZ606595A (en) 2014-08-29
MX2013001298A (es) 2013-03-08
AU2011288044A8 (en) 2014-08-07
CN103068398B (zh) 2015-08-19
KR20130073938A (ko) 2013-07-03
JP2013533292A (ja) 2013-08-22
EA201300159A1 (ru) 2013-11-29
EA025307B1 (ru) 2016-12-30

Similar Documents

Publication Publication Date Title
CN103068398A (zh) 丹参组合物在制备用于冠心病二级预防的药物中的用途
CN101444611B (zh) 治疗腰腿痛、腰椎间盘突出症的中药组合物及其制备方法
CN109758571A (zh) 一种促进尿酸代谢、改善痛风、保护关节的组合物及其制备方法
CN101085200B (zh) 一种治疗心力衰竭的中药组合物及其制备方法
CN105943958A (zh) 一种治疗痛风的桦褐孔菌复合固体颗粒及其制备方法
CN103933334B (zh) 一种治疗肺纤维化的药物组合物及其制备方法和用途
TWI584813B (zh) The use of Salvia miltiorrhiza in the preparation of a medicament for secondary prevention of coronary heart disease
CN110292607B (zh) 治疗高血压病并发左心室肥厚的中药组合物及制备方法
CN109758497B (zh) 用于慢性心力衰竭的中药组合物、药物及其制备方法和应用
CN106109951A (zh) 防治高血糖、高血脂、高血压的药物及其制备方法
CN107019778A (zh) 一种具有减肥和降血脂作用的组合物及其制备方法与用途
CN106177759A (zh) 一种治疗冠心病心绞痛的中药复方制剂及其制备工艺
CN101816698A (zh) 用于预防和治疗代谢紊乱综合症的组合物
CN102258622B (zh) 一种治疗糖尿病性冠心病的中药制剂及其制备方法
CN109528891A (zh) 一种防治冠心病稳定型心绞痛的中药制剂
CN109999076A (zh) 一种调节胆固醇逆转运的中药组合物及其应用
Mantelli et al. Laurel but Hardy: unintended poisoning, a case report of oleander misidentification as bay laurel
CN107205944A (zh) 用于纠正衰弱和/或慢性疲劳综合征的症状或治疗衰弱和/或慢性疲劳综合征的药物组合物
CN116688063A (zh) 一种清热解暑的中药组合物及其制备方法与应用
CN104739947A (zh) 一种养生防治三高药物及其制备方法
CN116672404A (zh) 一种用于治疗冠心病心绞痛的中药组合物及其制备方法与应用
CN108355079A (zh) 一种治疗焦虑症的药物组合物及其制备方法
US9050356B2 (en) Compositions comprising chitosan suitable for comprehensive therapeutic treatment or comprehensive prevention of the metabolic syndrome
CN111494497A (zh) 一种纯植物降压膏及其制备方法
CN102416035A (zh) 一种中药组合物在制备治疗冠心病心绞痛气虚血瘀证药物中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Yan Xijun

Inventor after: Wu Naifeng

Inventor after: Yan Kaijing

Inventor after: Sun He

Inventor after: Guo Zhicuan

Inventor after: Zhu Guoguang

Inventor after: Liu Weiwei

Inventor after: Zhao Libin

Inventor after: Luo Ruizhi

Inventor before: Yan Xijun

Inventor before: Wu Naifeng

Inventor before: Yan Kai

Inventor before: Sun He

Inventor before: Guo Zhicuan

Inventor before: Zhu Guoguang

Inventor before: Liu Weiwei

Inventor before: Zhao Libin

Inventor before: Luo Ruizhi

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: YAN XIJUN WU NAIFENG YAN KAI SUN HE GUO ZHIXIN ZHU GUOGUANG LIU WEIWEI ZHAO LIBIN LUO RUIZHI TO: YAN XIJUN WU NAIFENG YAN KAIJING SUN HE GUO ZHIXIN ZHU GUOGUANG LIU WEIWEI ZHAO LIBIN LUO RUIZHI

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1175994

Country of ref document: HK

CP03 Change of name, title or address

Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 (city of the modern Chinese Medicine)

Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd

Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 city of the modern Chinese Medicine

Patentee before: Tasly Pharmaceutical Group Co., Ltd.

CP03 Change of name, title or address